F1F2
England, Wales and Scotland
The manufacture or the formulation of a medicinal product if the process may result in the release into water of any substance described in Schedule 5 F3in a quantity which, in any 12 month period, exceeds the background quantity by more than the amount specified in relation to the description of substance in column 2 of that Schedule.
Annotations
Textual amendments
- F1
Regulations revoked (E.W.) (6.4.2008) by The Environmental Permitting (England and Wales) Regulations 2007 (S.I. 2007/3538), reg. 1(1)(b), Sch. 22 (with regs. 69-72); and lapsed (S.) by virtue of repeal of power conferring provision 1990 c. 43, s. 2 (S.) (1.4.2015) by Pollution Prevention and Control Act 1999 (c. 24), s. 7(3), Sch. 3 (with s. 7(7)); S.S.I. 2015/74, art. 2(2)(b)
- F2
Words in Sch. 1 s. 4.8 substituted (1.12.1994) by The Environmental Protection (Prescribed Processes and Substances Etc.) (Amendment) Regulations 1994 (S.I. 1994/1271), reg. 1, Sch. 3 para. 31 (with Sch. 6)
- F3
Words in Sch. 1 s. 4.8 added (8.1.1996) by The Environmental Protection (Prescribed Processes and Substances) (Amendment) Regulations 1995 (S.I. 1995/3247), reg. 1(1), Sch. 1 para. 6(c) (with Sch. 2)
Notes on Part CHAPTER 4: THE CHEMICAL INDUSTRY
Textual amendments
- F2
Words in Sch. 1 Ch. 4 added (1.12.1994) by The Environmental Protection (Prescribed Processes and Substances Etc.) (Amendment) Regulations 1994 (S.I. 1994/1271), reg. 1, Sch. 3 para. 23 (with Sch. 6)